ArticleClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association2022

Vedolizumab Is Associated With a Lower Risk of Serious Infections Than Anti-Tumor Necrosis Factor Agents in Older Adults.

Bharati Kochar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.